Data too important to share: do those who control the data control the message?
PublisherBMJ Publishing Group
MetadataShow full item record
DescriptionHydroxyethyl starch solutions for fluid resuscitation fell from grace in 2013 after European and American regulators issued severe warnings about their safety. But the academic investigators that led a landmark trial that helped precipitate this downfall are refusing to share their data. Is this acceptable? Peter Doshi reports.
CitationDoshi, P. (2016). Data too important to share: do those who control the data control the message? BMJ 2016;352:i1027. DOI: https://doi.org/10.1136/bmj.i1027
Hydroxyethyl Starch Derivatives
Clinical Trials as Topic
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/6602